Cargando…
A Glucose-Triptolide Conjugate Selectively Targets Cancer Cells under Hypoxia
A major hurdle in the treatment of cancer is chemoresistance induced under hypoxia that is characteristic of tumor microenvironment. Triptolide, a potent inhibitor of eukaryotic transcription, possesses potent antitumor activity. However, its clinical potential has been limited by toxicity and water...
Autores principales: | Datan, Emmanuel, Minn, Il, Xu, Peng, He, Qing-Li, Ahn, Hye-Hyun, Yu, Biao, Pomper, Martin G., Liu, Jun O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509213/ https://www.ncbi.nlm.nih.gov/pubmed/33083765 http://dx.doi.org/10.1016/j.isci.2020.101536 |
Ejemplares similares
-
A Unique Core–Shell Structured, Glycol Chitosan-Based Nanoparticle Achieves Cancer-Selective Gene Delivery with Reduced Off-Target Effects
por: Cheng, Bei, et al.
Publicado: (2022) -
Novel Carboxylated Chitosan-Based Triptolide Conjugate for the Treatment of Rheumatoid Arthritis
por: Zhang, Lan, et al.
Publicado: (2020) -
A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile
por: Boinapally, Srikanth, et al.
Publicado: (2021) -
In vivo antitumor effects of carboxymethyl chitosan-conjugated triptolide after oral administration
por: Zeng, Huahui, et al.
Publicado: (2020) -
Cetuximab-Triptolide Conjugate Suppresses the Growth of EGFR-Overexpressing Lung Cancers through Targeting RNA Polymerase II
por: Zhang, Keqiang, et al.
Publicado: (2020)